This cross-sectional study examined the association between ABO nonidentical transfusions and mortality in patients undergoing massive transfusion protocol (MTP).
No specific numerical results are available from the publisher page text; the full text is not accessible.
Full text is not yet publicly available (PMC embargo until 2027-09-16), so study-specific limitations, sample size, and outcome data cannot be assessed. The cross-sectional design limits causal inference.
Clinicians managing massive transfusion should be aware that ABO nonidentical blood products may be associated with mortality differences; however, specific guidance awaits full-text review of this study.
Explore related topics
